1.57
1.57 (-1.15%)
As of Mar 06, 2024
Bright Minds Biosciences Inc. [DRUG]
Source:
Company Overview
The Company is a biotechnology company dedicated to developing the next-generation therapeutics to improve the lives of patients with severe and life-altering diseases. The Company is focused on new chemical entities (NCEs) for a variety of central nervous system disorders, including but not limited to pediatric epilepsies, as well as other neuro-psychiatric disorders, including but not limited to depression. The Company's R&D efforts focus on medical indications based on its expertise in 5-HT (serotonin) mediated diseases.
Country | United States |
Headquarters | new york, new york |
Phone Number | 6474072515 |
Industry | |
CEO | Ian Mcdonald |
Website | www.brightmindsbio.com |